The natural history of gastric epithelial dysplasia and its relation to gastric cancer are ill defined. A consecutive series of 40 patients with an initial diagnosis of gastric epithelial dysplasia based on examination of endoscopic biopsies has been reviewed to determine the clinical outcome and to evaluate a two tier histological grading system as a predictor of the risk of cancer. On review, only 20 of the 40 patients were considered to have true dysplasia: seven patients had low grade dysplasia and 13 had high grade dysplasia. Of the 13 patients with high grade dysplasia, 11 (85%) were found to have gastric cancer within 15 months. Of the 10 patients with high grade dysplasia who underwent gastrectomy, six were found to have early gastric cancer, three had cancer invading into the muscularis propria, and none had lymph node metastases.
encountered in interpreting the changes in gastric biopsy specimens are similar to those experienced with ulcerative colitis, and therefore a system with only two grades of dysplasia has much to commend it.' A potential advantage of such a simple two grade classification is that the natural history and prognostic importance of each category can be identified more readily, which in turn allows more precise guidelines for clinical management to be formulated.
In this study we sought to determine the fate of all patients who were diagnosed as having gastric epithelial dysplasia over a five year period and to evaluate a two tier histological grading system as a predictor of the risk of cancer.
Methods
During the five years 1983 to 1987 inclusive, gastric epithelial dysplasia was diagnosed in 40 patients at the Leeds General Infirmary, and categorised by the reporting pathologist into mild, moderate, or severe grades9 or, more recently, into low grade or high grade dysplasia."' All the original biopsy specimens and any subsequent pathological material were reviewed and reclassified as (1) no dysplasia, (2) low grade dysplasia, (3) high grade dysplasia, and (4) carcinoma. Gastric cancer was classified
Little is known about the natural history of epithelial dysplasia in the stomach. Areas of epithelial dysplasia can often be found adjacent to established gastric cancer.' It is tempting to propose that gastric cancer arises from dysplastic epithelium just as colonic cancer arises from adenomas.4 Follow up studies of patients with dysplasia of the gastric epithelium tend to support this hypothesis,5-8 though the rate of progression to cancer appears to be slow.
A firm diagnosis of dysplasia made on the basis ofendoscopic biopsies raises two main problems: (a) Has gastric cancer been missed because of sampling error? (b) If dysplasia is present, is the risk of progression to cancer so great that the patient should be advised to undergo gastrectomy?
The degree or severity of dysplasia is obviously important. Gastric epithelial dysplasia is graded by most pathologists into mild, moderate, and severe categories. Cancer is diagnosed only if neoplastic cells breach the basement membrane of the epithelium and invade the lamina propria. The use of terms such as 'intraepithelial cancer' and 'carcinoma in situ' for lesions with the cytological appearances of cancer but without evidence of invasion of the lamina propria is discouraged.9 The difficulties gastric cancer and in high grade dysplasia are often identical. Carcinoma was diagnosed only if neoplastic cells were seen to be invading the lamina propria. Multiple sections through biopsy material were examined to reduce the likelihood of invasion being missed. Cases in which the original endoscopic biopsy material showed bizarre cytological and architectural appearances suspicious of carcinoma (Fig 3) , such as are sometimes seen in biopsy specimens from the margins of a tumour, were excluded from the study. Biopsy material with these appearances should not be classified as dysplasia.
Results
After histological review of the original specimen seven patients were classified as having low grade and 13 as having high grade dysplasia. In 19 of the 40 cases reviewed the appearances were not considered to represent true dysplasia, and in one case the diagnosis was changed to intramucosal carcinoma. The revised diagnoses in these patients are presented in Table I One patient with a large antral tumour, biopsy specimens of which showed high grade dysplasia, underwent a total gastrectomy with radical lymphadenectomy, without undergoing further endoscopy. The resected stomach contained an adenocarcinoma 8 cm in diameter which was invading the muscularis propria but not involving lymph nodes.
The remaining 11 patients with high grade dysplasia all had at least one further set of biopsy specimens taken at a repeat endoscopy. Four patients were found to have cancer in follow up biopsies within eight months; three underwent radical gastrectomy, of whom two had early gastric cancer (Ti NO MO) and one had cancer invading the muscularis propria (T2 NO MO). The fourth patient, who had cancer in a polyp, was unfit for surgical treatment and was referred for laser photocoagulation: repeat biopsies at first showed no further evidence of cancer, but one year after laser treatment biopsy specimens showed the presence of recurrent carcinoma.
In seven patients follow up endoscopy and biopsy over 1-15 months showed continuing high grade dysplasia without evidence of cancer. Six of these seven patients underwent radical gastrectomy, and five of them were found to have cancer: four had early gastric cancer (TI NO MO) and one had a T2 NO MO tumour. In the sixth patient, examination of the gastrectomy specimen showed high grade dysplasia but there was no evidence of carcinoma (the entire dysplastic area was processed for microscopic examination). The remaining patient with continuing high grade dysplasia was referred for laser photocoagulation of a small antral polyp. After destruction of the polyp there was regression to low grade dysplasia and then no dysplasia was found in three subsequent sets of specimens taken over a period of one year. Eighteen months after photocoagulation, however, a raised lesion was again seen at endoscopy: biopsy specimens showed no evidence of dysplasia, but because of the high degree of suspicion a further set was taken and the presence of high grade dysplasia was confirmed. This patient is a poor operative risk and is returning for further biopsies before a decision about further treatment is made.
The TNM staging of the 13 patients with high grade dysplasia in the original set of biopsy specimens is summarised in Table V. Patients with low grade dysplasia Of the seven patients with low grade dysplasia, four underwent further endoscopy and biopsy and three did not. In the four patients further biopsies after 2-24 months showed no evidence of dysplasia in three, while there was continuing low grade dysplasia in one patient after six months. Of the three patients who were not followed up, one failed to attend for further investigation, one was discharged, and the third died of an unrelated condition.
Patients reclassified as not having dysplasia In 19 patients the diagnosis was revised to gastritis with regenerative atypia (Table I) . None of these patients developed gastric carcinoma during a median follow up period of 18 months.
NUMBER OF BIOPSY SPECIMENS
Because ofthe retrospective nature of this review it was not possible to determine how many biopsy specimens were taken at each endoscopy in each patient, and when the number was indicated it was not always clear whether they had all been taken from the abnormal area of gastric mucosa. The number of sets of specimens taken in each patient was recorded. In patients with high grade dysplasia in the first set of specimens, in whom gastric cancer was diagnosed on the basis of follow up biopsies, the cancer was always found in either the second or the third set of specimens. Only one patient underwent gastrectomy on the basis of a single set of specimens that showed high grade dysplasia: this was because he had a large, malignant looking antral tumour at endoscopy. The other six patients who underwent gastrectomy on account ofhigh grade dysplasia had two to five sets Attempts to try to distinguish three different grades of severity of dysplasia may encourage the use of the term 'mild dysplasia' when the pathologist is presented with any biopsy specimen that shows minor cytological atypia. Many of these cases will represent regenerative atypia rather than a premalignant change and the patient will be subjected to unnecessary surveillance and anxiety. Of those patients with 'true' dysplasia the pathologist needs to identify a low risk group of patients who can safely be followed up by means of endoscopy and biopsy, and a high risk group of patients in whom the risk of cancer is sufficiently high to justify the use of gastrectomy. A group of patients with dysplasia of 'intermediate' severity is likely to contain patients of low and high risk, and inclusion of such a category therefore impedes clinical decision making. A further difficulty is that biopsy specimens taken at endoscopy are small and their interpretation may be difficult.'7 In the present study, when biopsy material was reviewed it was found that 16 of 23 cases originally reported as mild or low grade dysplasia had been misdiagnosed. Fifteen were reclassified as showing gastritis, with regenerative atypia, but one was reclassified as frank carcinoma. In contrast, no set of specimens originally thought to show severe or high grade dysplasia was reclassified as gastritis alone. Of the eight sets of specimens originally classified as moderate dysplasia, five were reclassified as gastritis, two as high grade dysplasia, and one as low grade dysplasia. No patient whose biopsy specimens were reclassified as gastritis developed gastric carcinoma during a median period of follow up of 18 months.
In this study dysplasia was most commonly associated with an ulcer. This is in keeping with the findings of previous studies.66 The The present study has highlighted the difficulty that can be experienced in demonstrating gastric cancer in patients presenting with high grade dysplasia even when carcinoma has invaded the muscularis propria. Although none of the patients in this series had metastases to lymph nodes, the risk of lymph node metastases is directly related to the depth of invasion of gastric cancer, being 2-4% for cancer invading the mucosa, 20% for cancer invading the submucosa, and over 40% for cancer invading the muscularis propria.' 24 In our own series of 27 patients who had early gastric cancers resected in the last 15 years, three (11%) had metastases to lymph nodes. We therefore consider radical gastrectomy with removal of the first and second tiers of lymph nodes to be the appropriate operative procedure for most patients with high grade dysplasia, but the age and general condition of the patient must obviously be taken into account and in some instances a less radical operation will be appropriate. Whether the gastrectomy should be total or subtotal depends on the site and extent ofdysplasia in the stomach. In our series two patients had more than one focus of cancer, but in both cases the cancerous foci were adjacent to each other. Thus we found no evidence of widespread high grade dysplasia in the stomach, and our data lend no support to the idea that all patients with high grade dysplasia should undergo total gastrectomy. If subtotal gastrectomy is to be carried out, however, it is important that biopsy specimens be taken from all regions of the stomach before operation so that areas ofabnormal mucosa may be mapped out accurately.
The conclusion from this study, that a histological diagnosis of high grade dysplasia is usually an indication for gastrectomy because of the almost invariable association of high grade dysplasia with invasive carcinoma, places a heavy responsibility on the reporting pathologist. The recognition of dysplasia, and its distinction from atypical hyperplasia consequent upon regeneration or inflammatory activity, is far from straightforward. Indeed, such changes may be so bizarre as to give rise to appearances indistinguishable from malignancy. It is obligatory therefore for the diagnosis of high grade dysplasia to be confirmed by a second set of biopsy specimens, while the biopsy specimens themselves must be reported on by very experienced pathologists. Where expert advice is not available locally, submission of biopsy specimens showing dysplasia to a specialised pathological panel for review should improve diagnostic accuracy and reduce the risk of unnecessary gastrectomy.
